Although biochemical parameters such as ALT are widely used and inexpensive, due to its limitations, there is a strong need for other noninvasive modalities such as elastography to improve the management of pediatric NAFLD. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.